Brain PET scans help select and monitor patients for new Alzheimer's drugs
Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer's disease, helping clinicians visualize the biological changes associated with the condition and guide decisions about new therapies. Amyloid PET imaging is being used to confirm the presence of amyloid pathology and support treatment decisions for patients receiving anti-amyloid drugs, while…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
1990 to 2023 saw increase in global burden of acne
United Kingdom
-
Early MS treatments impact relapses and brain scarring differently, but not disability
United Kingdom
-
Disability burden linked to alcohol-related cirrhosis and heart failure projected to rise sharply by 2050
United Kingdom
-
Napping linked to dementia risk
United Kingdom
-
Having insurance doesn't mean you can get a mental health appointment
United Kingdom
-
Genomic cancer driver study reveals new clues to why some prostate cancers become aggressive
United Kingdom
-
Menopause hormone therapy gets stronger endorsement from OB-GYNs in expanded guideline
United Kingdom
-
Strong food preferences may help explain why changing eating habits is hard
United Kingdom